
Clinical small-series
manufacturing
ISO 13485-certified production of clinical trial units, and the industrialisation pathway that makes your CDMO transfer straightforward.
Protomed produces small series of minimally invasive medical devices for clinical trials and early launches. ISO 13485:2016 certified since 2006, we manufacture complete finished devices (nitinol implants, injected parts, precision shafts), delivered under industrial production conditions. The real value: the manufacturing chain we build to produce them. Validated processes, qualified suppliers, documented instructions, transferable directly to a CDMO when you're ready. Our services are eligible for the French Research Tax Credit (CIR) and Innovation Tax Credit (CII). We provide the necessary documentation.
Not sure yet how many units you'll need, or when? Tell us about your clinical programme, we'll get back to you within 48h.
What do we produce?
We produce complete finished medical devices, assembled, tested and documented to the same standard as industrial production. This includes:
Delivery systems
Complete catheter-based delivery systems including all sub-assemblies. We coordinate sub-contracted components (nitinol implants, precision shafts, injected parts) and integrate them into finished device assemblies.
Multi-lumen catheters
Complex catheter architectures assembled in-house using our extrusion, braiding, coating and micro-assembly capabilities. Balloon integration and hub attachment included.
Implant mechanical components
Surgical instrumentation & endoscopic accessories
Structural and mechanical parts for active implants; we handle mechanical assembly. Nitinol forming, silicone components, precision metal parts sourced through qualified partners.
MIS instrumentation assembled to final specifications. Component sourcing coordinated through our qualified supplier network.
Where required, we produce in our cleanroom (ISO class 8), with packaging and labelling to finished product standard. Every unit produced is traceable, documented and manufactured in accordance with a validated manufacturing instruction.
We build your pre-series, but that's not all we do.
That's the fundamental difference between Protomed's small-series capability and a prototyping shop that can produce a few extra units. When we set up a production run, we design it as if it were being handed over to a CDMO the next day: manufacturing instructions written to production standard (not bench notes), process parameters defined and validated (IQ/OQ/PQ where applicable), component suppliers formally qualified to ISO 13485 supplier management requirements, each unit tested against documented acceptance criteria, batch records maintained for every production run. When your clinical trial ends and you're ready to scale, the manufacturing transfer to a CDMO isn't a reinvention. The instructions, qualifications and validation data already exist. The CDMO takes your dossier and scales it, rather than starting over from your design. This approach also reduces clinical phase risk. If a manufacturing issue appears during clinical unit production, it appears now, not during a commercial launch industrial run.
We design the manufacturing chain you'll actually need.
The transfer Pathway
Our small-series manufacturing is explicitly designed as a bridge, not a destination. We position every production engagement within a clear transfer pathway:
We step in where we can make a difference. And when a client brings us a brief we think can be improved, we say so, because fixing a design in phase 2 always costs less than fixing it in phase 4.
ISO 13485 Certified Production : Every Unit Traceable
Every unit we produce is manufactured within our ISO 13485:2016-certified quality system. For clinical trial units specifically, this documentation package is structured to meet the requirements of your clinical investigation plan and to satisfy the expectations of your competent authority. Every lot is produced as if it will be audited.
Batch records maintained for every production run; component lot numbers, process parameters, inspection results.
Acceptance testing performed against documented criteria for every unit.
Non-conforming units identified, segregated, and dispositioned through our NCR process.
CAPA process for any production non-conformances; root cause, corrective action, verification.
Complete traceability from raw material to finished device.
Start your manufacturing project
Tell us about your device, your clinical programme, and your timeline. We will respond within 48 hours with an initial assessment of scope and feasibility.
FREQUENTLY ASKED QUESTIONS
Your question isn't here?
Ask us directly. We respond to every inquiry personally, within 48 hours.
© 2026. All rights reserved.

Site map
Contract medical device development in cardiovascular and minimally invasive surgery.


